For submonolayer quantum dot (QD) based photonic devices, size and density of QDs are critical parameters, the probing of which requires indirect methods. We report the determination of lateral size distribution of type-II ZnTe/ZnSe stacked submonolayer QDs, based on spectral analysis of the optical signature of Aharanov-Bohm (AB) excitons, complemented by photoluminescence studies, secondary-ion mass spectroscopy, and numerical calculations. Numerical calculations are employed to determine the AB transition magnetic field as a function of the type-II QD radius. The study of four samples grown with different tellurium fluxes shows that the lateral size of QDs increases by just 50%, even though tellurium concentration increases 25-fold. Detailed spectral analysis of the emission of the AB exciton shows that the QD radii take on only certain values due to vertical correlation and the stacked nature of the QDs.
Linearly polarized photoluminescence is observed for type-II ZnTe/ZnSe submonolayer quantum dots (QDs). The comparison of spectral dependence of the degree of linear polarization (DLP) among four samples indicates that the optical anisotropy is mostly related to the elongation of ZnTe QDs. Numerical calculations based on the occupation probabilities of holes in px and py orbitals are performed to estimate the lateral aspect ratio of the QDs, and it is shown that it varies between 1.1 and 1.4. The value of anisotropic exchange splitting for bright excitonic states is found to be ∼200 μeV from the measurement of the degree of circular polarization as a function of the magnetic field. The results also show that heavy-light hole mixing ratio is about 0.16.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.